Ubiquitome offers genomic information solutions with portable cloud-connected genetic analysis devices.
Ubiquitome has raised $281K in total funding. The most recent round was Grant. The last funding was announced in September 2021.
Ubiquitome's investors include Callaghan Innovation.
Ubiquitome is headquartered in Auckland, New Zealand.
Ubiquitome offers genomic information solutions with portable cloud-connected genetic analysis devices.
Ubiquitome is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ubiquitome — Funding & Investors." VCBacked, September 14, 2021, https://www.vcbacked.co/company/ubiquitome. Accessed November 12, 2026.
VCBacked. (2021). Ubiquitome — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/ubiquitome
{{cite web |title=Ubiquitome — Funding & Investors |url=https://www.vcbacked.co/company/ubiquitome |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Ubiquitome? Request a listing update